Rosiglitazone (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rosiglitazone" in French language version.

refsWebsite

Global rank French rank

2thelancet.com

2,393^rd place

506^th place

2nejm.org

2,374^th place

298^th place

220minutes-blogs.fr

low place

5,836^th place

2ama-assn.org

3,257^th place

1,028^th place

1qmul.ac.uk

1,735^th place

168^th place

1afssaps.fr

low place

3,181^st place

1msn.com

117^th place

258^th place

1ahajournals.org

3,608^th place

659^th place

1wiley.com

222^nd place

129^th place

1sciencedirect.com

149^th place

80^th place

1fda.gov

447^th place

1,409^th place

1lesoir.be

1,371^st place

85^th place

20minutes-blogs.fr

pharmacritique.20minutes-blogs.fr

afssaps.fr

Communiqué de l'AFSSAPS du 23 septembre 2010 [1]

ahajournals.org

circoutcomes.ahajournals.org

Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population [4], © 2010 American Heart Association, Inc.

ama-assn.org

jama.ama-assn.org

Lipscombe et al. Thiazolidinediones and Cardiovascular Outcomes in Older Patients With Diabetes, JAMA, 2007;298:2634–2643
Lincoff AM, Wolski K, Nicholls SJ, Nissen, SE, Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus : A meta-analysis of randomized trials, JAMA, 2007;298:1180-1188

fda.gov

FDA, FDA Drug Safety Podcast: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines, 27 novembre 2013

lesoir.be

GSK aurait tenté de dissimuler les risques d'un antidiabétique - Le Soir 14 juillet 2010

msn.com

msnbc.msn.com

Dépêche de l'Associated Press du 23 septembre 2010

nejm.org

content.nejm.org

Nissen SE, Wolski K, Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes, New Eng J Med, 2007:356:2457-2471
Psaty BM, Furberg CD, Rosiglitazone and cardiovascular risk, New Eng J Med, 2007:356:2522-2524

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

sciencedirect.com

Home PD, Pocock SJ, Beck-Nielsen H et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial, Lancet, 2009;373:2125-35

thelancet.com

wiley.com

onlinelibrary.wiley.com

Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin–angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20)[5], Journal of Diabetes, Volume 2, Issue 3, pages 212–220, September 2010